Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study

BACKGROUND: The duration of protection against the omicron (B.1.1.529) variant for current COVID-19 vaccines is not well characterised. Vaccine-specific estimates are especially needed. We aimed to evaluate the effectiveness and durability of two and three doses of the BNT162b2 (Pfizer–BioNTech) mRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Tartof, Sara Y, Slezak, Jeff M, Puzniak, Laura, Hong, Vennis, Xie, Fagen, Ackerson, Bradley K, Valluri, Srinivas R, Jodar, Luis, McLaughlin, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033225/
https://www.ncbi.nlm.nih.gov/pubmed/35468336
http://dx.doi.org/10.1016/S2213-2600(22)00101-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033225/
https://www.ncbi.nlm.nih.gov/pubmed/35468336
http://dx.doi.org/10.1016/S2213-2600(22)00101-1

Ejemplares similares